Anti-BMCA Bispecific Antibodies - Independent Symposium at the 10th World Congress on Controversies in Multiple Myeloma (COMy)
By
Springer Healthcare IME
FEATURING
Saad Usmani
By
Springer Healthcare IME
FEATURING
Saad Usmani
Chaired by Mohamad Mohty, and featuring Rakesh Popat, Suzanne Lentzsch and Saad Usmani, this CME-accredited symposium focussed on an overview of the multifaceted landscape of BCMA-targeting strategies in multiple myeloma, including anti-BCMA bispecific antibodies, anti-BCMA ADCs, and anti-BCMA CAR-T cells, offering insights into the latest clinical data and their implications for clinical practice. The session concluded with a comprehensive discussion addressing challenges and future needs in myeloma therapy.
Independent symposium organized by Springer Healthcare IME. This program is made possible thanks to an educational grant received from GlaxoSmithKline.
Independent symposium organized by Springer Healthcare IME. This program is made possible thanks to an educational grant received from GlaxoSmithKline.
Comments 0
Login to view comments.
Click here to Login
